Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mohr

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2007
[Adjuvant interferon therapy in malignant melanoma]Peter Mohr
MMW Fortschritte Der Medizin|April 14, 2016
[Deep freezing, curettage or rather cream application]Peter Mohr, Christine Starostzik
Oncology Research and Treatment|May 14, 2015
[Rationale, visions and limits of Immuno-oncology: Checkpoint inhibition as a new pillar of tumor therapy]Axel Hauschild, Peter Mohr
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Axel Hauschild, Peter Mohr
Advances in Therapy|May 28, 2024
BRAF<sup>V600E</sup> Metastatic Melanoma Journey: A Perspective from a Patient and his OncologistCarsten Finke, Peter Mohr
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 11, 2020
Selma Ugurel, Peter Mohr
Journal of Medicinal Chemistry|February 24, 2010
Intramolecular hydrogen bonding in medicinal chemistryBernd Kuhn, Peter Mohr, Martin Stahl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2021
Update - Systemtherapie beim BasalzellkarzinomUlrike Leiter-Stöppke, Peter Mohr, Ralf Gutzmer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanomaPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 24, 2007
Linearity of the dose monitor system at low monitor unitsPeter Mohr, Sabrina Brieger, Jürgen Stahl, et al.
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2007
[Adjuvant interferon therapy in malignant melanoma]Peter Mohr
MMW Fortschritte Der Medizin|April 14, 2016
[Deep freezing, curettage or rather cream application]Peter Mohr, Christine Starostzik
Oncology Research and Treatment|May 14, 2015
[Rationale, visions and limits of Immuno-oncology: Checkpoint inhibition as a new pillar of tumor therapy]Axel Hauschild, Peter Mohr
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Axel Hauschild, Peter Mohr
Advances in Therapy|May 28, 2024
BRAF<sup>V600E</sup> Metastatic Melanoma Journey: A Perspective from a Patient and his OncologistCarsten Finke, Peter Mohr
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 11, 2020
Selma Ugurel, Peter Mohr
Journal of Medicinal Chemistry|February 24, 2010
Intramolecular hydrogen bonding in medicinal chemistryBernd Kuhn, Peter Mohr, Martin Stahl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2021
Update - Systemtherapie beim BasalzellkarzinomUlrike Leiter-Stöppke, Peter Mohr, Ralf Gutzmer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanomaPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 24, 2007
Linearity of the dose monitor system at low monitor unitsPeter Mohr, Sabrina Brieger, Jürgen Stahl, et al.
Pageof 19